Trial intelligence / Profile preview

rhHNS Intrathecal in MPS IIIA

NCT01155778Phase 2Completed

Sponsor
Takeda
Start
Jun 2010
Primary completion
Sep 2012
Modality
Replacement Enzymes
Countries
2
01

Overview

A Phase 2 trial of recombinant human heparan-N-sulfatase in Sanfilippo syndrome type A, sponsored by Takeda. Started Jun 2010; status: completed.

02

Drugs

recombinant human heparan-N-sulfatase
03

Conditions

Sanfilippo syndrome type A

Beyond the preview

Go deeper on NCT01155778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01155778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call